Skip to content

PolitiKit

Lobbying by The Canada Life Assurance Company: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

The Canada Life Assurance Company

Meetings this Parliament
10
With MPs
1
Since Nov 2021
12
Active registrations
1

Most recent reported meeting: Mar 26, 2026.

Registrations in effect

Consultant In effect since Feb 11, 2026

Consultant Regan Watts of Fratton Park Inc.

Consultant lobbyists

  • Regan Watts Former designated public office holder

    Formerly Director - Strategic Planning, Minister’s Office, Finance Canada (2010–2012)

    Formerly Senior Policy Advisor, Minister’s Office, Foreign Affairs and International Trade Canada (2009–2010)

    Formerly Director - Parliamentary Affairs, Minister’s Office, Health Canada (2008–2009)

    Formerly Policy Advisor - Infrastructure, Minister’s Office, Transport, Infrastructure and Communities (2007–2008)

Institutions they may lobby: Canada Border Services Agency (CBSA), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Communications Security Establishment Canada (CSEC), Competition Bureau Canada (COBU), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Financial Consumer Agency of Canada (FCAC), Financial Transactions and Reports Analysis Centre of Canada (FINTRAC), Health Canada (HC), House of Commons, Housing, Infrastructure and Communities Canada (HICC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Justice Canada (JC), Office of the Privacy Commissioner of Canada (OPC), Office of the Superintendent of Financial Institutions Canada (OSFI), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada, Transport Canada (TC)

What they're lobbying on (12)
  • Federal tax policy and regulatory matters concerning the application of GST/HST to mutual fund trailing commissions. Engagement regarding implementation timelines, administrative guidance, and related impacts on financial services firms and investors.
  • Digital Services Taxes and the introduction of Internal Revenue Code (IRC) Section 899 included in a recent Bill passed through the United States House of Representatives.
  • Discussion of taxation policy for financial institutions relating to dividends, share buybacks, and general corporate tax rates.
  • Working with policy makers to ensure adequate pension and retirement products and services are available to Canadians.
  • To ensure that the needs of the financial sector in matters related to human resources as well as its capacity to service customers are properly reflected in legislation, policies and regulations in the context of the COVID-19 public health and economic crisis.
  • The Personal Information Protection and Electronic Documents Act with respect to privacy, customer data, and data security
  • Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations
  • Review of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act as it relates to insurance contracts.
  • Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
  • Guidelines of the Office of the Superintendent of Financial Institutions as they relate to insurance companies.
  • Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
  • Clarification of Goods and Services Tax (GST) / Harmonized Sales Tax (HST) with respect to the treatment of financial services.

Registration 945127-379889-5. Look it up in the official Registry

Reported meetings

Spreadsheet
  • Reported by Regan Watts · Consultant

    • Julien Brazeau · Assistant Deputy Minister, Finance Canada (FIN)
    Federal tax policy and regulatory matters concerning the application of GST/HST to mutual fund trailing commissions. Engagement regarding implementation timelines, administrative guidance, and related impacts on financial services firms and investors. Read more

    Official report

  • Reported by Regan Watts · Consultant

    Federal tax policy and regulatory matters concerning the application of GST/HST to mutual fund trailing commissions. Engagement regarding implementation timelines, administrative guidance, and related impacts on financial services firms and investors. Read more

    Clarification of Goods and Services Tax (GST) / Harmonized Sales Tax (HST) with respect to the treatment of financial services.

    Official report

  • Reported by Regan Watts · Consultant

    • Jerome Côté · Senior Policy Advisor, Finance Canada (FIN)
    Federal tax policy and regulatory matters concerning the application of GST/HST to mutual fund trailing commissions. Engagement regarding implementation timelines, administrative guidance, and related impacts on financial services firms and investors. Read more

    Official report

  • Reported by Regan Watts · Consultant

    • Matthew O'Connell · Deputy Director Financial Sector Policy, Finance Canada (FIN)
    Discussion of taxation policy for financial institutions relating to dividends, share buybacks, and general corporate tax rates. Read more

    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

  • Reported by Regan Watts · Consultant

    • Julien Brazeau · Assistant Deputy Minister, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology Read more

    Discussion of taxation policy for financial institutions relating to dividends, share buybacks, and general corporate tax rates.

    Working with policy makers to ensure adequate pension and retirement products and services are available to Canadians.

    Official report

  • Reported by Regan Watts · Consultant

    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    The Personal Information Protection and Electronic Documents Act with respect to privacy, customer data, and data security

    Official report

  • Reported by Regan Watts · Consultant

    • Aaron Wudrick · Director of Policy, House of Commons
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology Read more

    Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations

    Official report

  • Reported by Regan Watts · Consultant

    • Maude Lavoie · Associate Assistant Deputy Minister, Finance Canada (FIN)
    Digital Services Taxes and the introduction of Internal Revenue Code (IRC) Section 899 included in a recent Bill passed through the United States House of Representatives. Read more

    Official report

  • Reported by Regan Watts · Consultant

    • Michael Mosier · Director, Finance Canada (FIN)
    Digital Services Taxes and the introduction of Internal Revenue Code (IRC) Section 899 included in a recent Bill passed through the United States House of Representatives. Read more

    Official report

  • Reported by Regan Watts · Consultant

    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Eric Costen · Associate Deputy Minister, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations

    Official report

  • Reported by Regan Watts · Consultant

    Working with policy makers to ensure adequate pension and retirement products and services are available to Canadians. Read more

    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services

    Official report

  • Reported by Regan Watts · Consultant

    • Eric Costen · Associate Deputy Minister, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.